Your browser doesn't support javascript.
loading
Lower end of treatment HBsAg and HBcrAg were associated with HBsAg loss after nucleos(t)ide analog cessation.
Xie, Yandi; Li, Minghui; Ou, Xiaojuan; Zheng, Sujun; Gao, Yinjie; Xu, Xiaoyuan; Yang, Ying; Ma, Anlin; Li, Jia; Nan, Yuemin; Zheng, Huanwei; Liu, Juan; Wei, Lai; Feng, Bo.
Affiliation
  • Xie Y; Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Diseases, Peking University People's Hospital, Peking University Hepatology Institute, Beijing International Cooperation Base for Science and Technology on NAFLD Diagnosis, Beijing, 100044, China.
  • Li M; Department of Hepatology Division, Beijing Ditan Hospital, Capital Medical University, Beijing, 100015, China.
  • Ou X; Liver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing, 100050, China.
  • Zheng S; Complicated Liver Diseases and Artificial Liver Treatment and Training Center, Beijing Municipal Key Laboratory of Liver Failure and Artificial Liver Treatment and Research, Beijing Youan Hospital, Capital Medical University, Beijing, 100069, China.
  • Gao Y; Department of Infectious Diseases, The Fifth Medical Center, General Hospital of PLA, Beijing, 100039, China.
  • Xu X; Department of Infectious Diseases, Peking University First Hospital, Beijing, 100034, China.
  • Yang Y; Department of Infectious Diseases, The Second Hospital of Xingtai, Xingtai, Hebei, 054001, China.
  • Ma A; Department of Infectious Disease, Friendship Hospital, Beijing, 100029, China.
  • Li J; Department of Liver Disease, Tianjin Second People's Hospital, Tianjin, 300192, China.
  • Nan Y; Department of Traditional and Western Medical Hepatology, The Third Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050051, China.
  • Zheng H; Department of Liver Disease, Shijiazhuang Fifth Hospital, Shijiazhuang, Hebei, 050021, China.
  • Liu J; Research Center for Technologies in Nucleic Acid-Based Diagnostics, Changsha, Hunan, 410205, China.
  • Wei L; Department of Hepatopancreatobiliary Disease, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, 102218, China.
  • Feng B; Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Diseases, Peking University People's Hospital, Peking University Hepatology Institute, Beijing International Cooperation Base for Science and Technology on NAFLD Diagnosis, Beijing, 100044, China. fengbo@pkuph.edu.cn.
BMC Gastroenterol ; 23(1): 224, 2023 Jun 29.
Article in En | MEDLINE | ID: mdl-37386460
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hepatitis B e Antigens / Hepatitis B Surface Antigens Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Asia Language: En Journal: BMC Gastroenterol Journal subject: GASTROENTEROLOGIA Year: 2023 Document type: Article Affiliation country: China Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hepatitis B e Antigens / Hepatitis B Surface Antigens Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Asia Language: En Journal: BMC Gastroenterol Journal subject: GASTROENTEROLOGIA Year: 2023 Document type: Article Affiliation country: China Country of publication: United kingdom